Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-24

Clinical Trial Update: Bromelain and Cardiovascular Risk Factors in Diabetes [NA]

View source ↗

Summary

A completed clinical trial investigated bromelain's effects on cardiovascular risk factors in individuals with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromelain (bromelain)

Snippet

Sponsor: Hebei Yiling Hospital | Conditions: Cardiovascular Disease. | NA | Status: COMPLETED